These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29485946)

  • 21. The effect of an interprofessional pain service on nonmalignant pain control.
    Coffey CP; Ulbrich TR; Baughman K; Awad MH
    Am J Health Syst Pharm; 2019 May; 76(Supplement_2):S49-S54. PubMed ID: 30854542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program.
    Lavitas P; Tesell M; Hydery T; Greenwood BC; Price M; Lenz K; Jeffrey P
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1161-6. PubMed ID: 27668564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using electronic health record's data to assess daily dose of opioids prescribed for outpatients with chronic non-cancer pain.
    Tuan WJ; Sehgal N; Zgierska AE
    Fam Med Community Health; 2021 Nov; 9(Suppl 1):. PubMed ID: 34819321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of a Retrospective Drug Utilization Review on Potentially Unsafe Opioid and Central Nervous System Combination Therapy.
    Qureshi N; Wesolowicz LA; Liu CM; Tungol Lin A
    J Manag Care Spec Pharm; 2015 Oct; 21(10):938-44. PubMed ID: 26402392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial.
    Sullivan MD; Turner JA; DiLodovico C; D'Appollonio A; Stephens K; Chan YF
    J Pain; 2017 Mar; 18(3):308-318. PubMed ID: 27908840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians.
    Henry SG; Paterniti DA; Feng B; Iosif AM; Kravitz RL; Weinberg G; Cowan P; Verba S
    J Pain; 2019 Feb; 20(2):181-191. PubMed ID: 30243859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System.
    Hundley L; Spradley S; Donelenko S
    J Opioid Manag; 2018; 14(2):89-101. PubMed ID: 29733095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
    Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
    J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "I'm Not Gonna Pull the Rug out From Under You": Patient-Provider Communication About Opioid Tapering.
    Matthias MS; Johnson NL; Shields CG; Bair MJ; MacKie P; Huffman M; Alexander SC
    J Pain; 2017 Nov; 18(11):1365-1373. PubMed ID: 28690000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
    Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
    Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "I really had somebody in my corner." Patient experiences with a pharmacist-led opioid tapering program.
    Schneider JL; Firemark AJ; Papajorgji-Taylor D; Reese KR; Thorsness LA; Sullivan MD; DeBar LL; Smith DH; Kuntz JL
    J Am Pharm Assoc (2003); 2023; 63(1):241-251.e1. PubMed ID: 35718714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations.
    Hartung DM; Alley L; Leichtling G; Korthuis PT; Hildebran C
    Addict Behav; 2018 Nov; 86():32-39. PubMed ID: 29754987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Opioid Crisis in the United States: Chronic Pain Physicians Are the Answer, Not the Cause.
    Brown RE; Sloan PA
    Anesth Analg; 2017 Nov; 125(5):1432-1434. PubMed ID: 29049104
    [No Abstract]   [Full Text] [Related]  

  • 37. Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)-efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up.
    Henrik G; Patrik M; Anders H; Ulf J; Marcelo RF; Åsa R
    Trials; 2021 Jul; 22(1):503. PubMed ID: 34321058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing High-Dose Opioid Prescribing: State-Level Morphine Equivalent Daily Dose Policies, 2007-2017.
    Heins SE; Frey KP; Alexander GC; Castillo RC
    Pain Med; 2020 Feb; 21(2):308-316. PubMed ID: 30865779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A physician-pharmacist collaborative care model to prevent opioid misuse.
    Lagisetty P; Smith A; Antoku D; Winter S; Smith M; Jannausch M; Mi Choe H; Bohnert ASB; Heisler M
    Am J Health Syst Pharm; 2020 May; 77(10):771-780. PubMed ID: 32315401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and Evaluation.
    Kuntz JL; Schneider JL; Firemark AJ; Dickerson JF; Papajorgji-Taylor D; Reese KR; Hamer TA; Marsh D; Thorsness LA; Sullivan MD; Debar LL; Smith DH
    Perm J; 2020; 24():. PubMed ID: 33196429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.